Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Check Point Software Tech Q4 Adj EPS $2.45 Beats $2.19 Estimate, Sales $638.50M Beat $593.03M Estimate

Check Point Software Tech (NASDAQ:CHKP) reported quarterly earnings of $2.45 per share which beat the analyst consensus estimate of $2.19 by 11.87 percent. This is a 8.89 percent increase over earnings of $2.25 per share
byBenzinga Newsdesk
February 13, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Check Point Software Tech (NASDAQ:CHKP) reported quarterly earnings of $2.45 per share which beat the analyst consensus estimate of $2.19 by 11.87 percent. This is a 8.89 percent increase over earnings of $2.25 per share from the same period last year. The company reported quarterly sales of $638.50 million which beat the analyst consensus estimate of $593.03 million by 7.67 percent. This is a 6.58 percent increase over sales of $599.10 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Gilead’s Kites Announced Body of Evidence Grows From ZUMA-7 Study Supporting Initial Treatment With Yescarta CAR T-cell Therapy for Patients With Relapsed or Refractory Large B-cell Lymphoma at ASH 2022

By Charles Gross
December 11, 9:13 PM
Kite, a Gilead Company (Nasdaq: GILD), today announced findings from two new analyses of the landmark ZUMA-7 trial of Yescarta® (axicabtagene ciloleucel), the largest and longest follow-up of a CAR T-cell therapy versus standard of care (SOC) in patients with relapsed or refractory large B-cell lymphoma (r/r LBCL).

GILD